imgboxbg
搜索
搜索
技术支持
真诚合作、互利共赢、卓越品质,用心服务
关于我们
/
/
/
Biortus Delivering hERG Protein and Cryo-EM Structures

Biortus Delivering hERG Protein and Cryo-EM Structures

  • 分类:News
  • 作者:
  • 来源:
  • 发布时间:2022-04-26
  • 访问量:0

【概要描述】As part of the drug safety assessment practice, ion channels are one of the key family proteins under tight scrutiny with almost every drug candidate. Unfortunately, as of now the effect of drug candi

Biortus Delivering hERG Protein and Cryo-EM Structures

【概要描述】As part of the drug safety assessment practice, ion channels are one of the key family proteins under tight scrutiny with almost every drug candidate. Unfortunately, as of now the effect of drug candi

  • 分类:News
  • 作者:
  • 来源:
  • 发布时间:2022-04-26
  • 访问量:0
详情

As part of the drug safety assessment practice, ion channels are one of the key family proteins under tight scrutiny with almost every drug candidate. Unfortunately, as of now the effect of drug candidates on ion channels are only being evaluated by affinity screening, and medicinal chemists can only rely on empirical estimates to modify the drug candidate if a candidate has undesirable affinity to certain ion channels. To help medicinal chemists improve the safety mitigation process, Biortus is building toolboxes for structure-guided affinity design-out on a panel of ion channels as part of Biortus’s IonChannelSuite® Campaign.

Figure 1. Recombinant hERG: (A) Size exclusion chromatography, and (B) SDS-PAGE

Figure 2. Cryo-EM structure of recombinant hERG: (A). Cryo-EM image and 2D classification of hERG, (B). Local resolution estimation, (C). Density in the central cavity of core region, (D). Close-up views of binding mode of the three potassium ions.

 

The first example of the panel is hERG, a potassium channel directly involved in cardiovascular toxicity for some drug candidates [1,2]. Biortus’s team has established a robust hERG expression and purification process and delivered large quantity of pure and stable hERG protein sample for activity profiling and structural biology studies (Fig. 1). Taking advantage of its state-of-the-art cryo-EM facility, Biortus’s cryo-EM team has solved hERG structure to 2.5Å resolution (Fig. 2) [3, 4, 5, 6]. The complete package of protein to assay to structure on hERG and other ion channels prepared by Biortus’s team presents powerful toolboxes to mitigate drug candidates’ safety concerns.

 

 

[1] Heijman, Jordi, et al. "Cardiac safety assays." Current opinion in pharmacology 15 (2014): 16-21.
[2] Sanguinetti, Michael C., and Martin Tristani-Firouzi. "hERG potassium channels and cardiac arrhythmia." Nature 440.7083 (2006): 463-469.
[3] Garrido, Amanda, et al. "hERG toxicity assessment: Useful guidelines for drug design." European Journal of Medicinal Chemistry 195 (2020): 112290.
[4] Zhou, S. B., Jiang Wang, and Hong Liu. "Lead compound optimization strategy (5)–reducing the hERG cardiac toxicity in drug development." Yao xue xue bao= Acta Pharmaceutica Sinica 51.10 (2016): 1530-1539.
[5] Wang, Weiwei, and Roderick MacKinnon. "Cryo-EM structure of the open human ether-à-go-go-related K+ channel hERG." Cell 169.3 (2017): 422-430.
[6] Asai, Tatsuki, et al. "Cryo-EM structure of K+-bound hERG channel complexed with the blocker astemizole." Structure 29.3 (2021): 203-212.

扫二维码用手机看

联系我们

联系电话:+86 (510) 8613-0005

公司地址:江苏省江阴市东盛西路6号A5楼

电子邮箱:info@wuxibiortus.com

二维码

WeChat

Copyright © 无锡佰翱得生物科学有限公司     苏ICP备15024653号-1

佰翱得生物

Copyright © 2020 佰翱得生物

苏ICP备15024653号-1  网站建设:中企动力 江阴